Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose ETC Chemotherapy with Stem Cell Rescue in Ovarian Cancer
NCT00005612Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Aug 1999
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan in ovarian epithelial cancer, sponsored by Moffitt Cancer Center. Primary endpoint: Progression free survival at 5 years. Started Aug 1999; status: terminated.
02
Drugs
topotecan
03
Conditions
ovarian epithelial cancer
Beyond the preview
Go deeper on NCT00005612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005612.